[1] 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[2] LALU MM, MAZZARELLO S, ZLEPNIG J, et al. Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta-Analysis. Stem Cells Transl Med. 2018;7(12):857-866.
[3] SHEN C, SHENG Y, ZHU AC, et al. RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia. Cell Stem Cell. 2020;27(1):64-80.e9.
[4] BOO SH, KIM YK. The emerging role of RNA modifications in the regulation of mRNA stability. Exp Mol Med. 2020;52(3):400-408.
[5] KAKKAR A, NANDY SB, GUPTA S, et al. Adipose tissue derived mesenchymal stem cells are better respondents to TGFβ1 for in vitro generation of cardiomyocyte-like cells. Mol Cell Biochem. 2019; 460(1-2):53-66.
[6] ABD EMAMI B, MAHMOUDI E, SHOKRGOZAR MA, et al. Mechanical and Chemical Predifferentiation of Mesenchymal Stem Cells Into Cardiomyocytes and Their Effectiveness on Acute Myocardial Infarction. Artif Organs. 2018;42(6):E114-E126.
[7] DOMINICI M, LE BLANC K, MUELLER I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.
[8] GRAU-VORSTER M, LAITINEN A, NYSTEDT J, et al. HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study. Stem Cell Res Ther. 2019;10(1):164.
[9] JIANG W, XU J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53(1):e12712.
[10] ABUMAREE MH, ABOMARAY FM, ALSHABIBI MA, et al. Immunomodulatory properties of human placental mesenchymal stem/stromal cells. Placenta. 2017;59:87-95.
[11] WANG Y, CHEN X, CAO W, et al. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014;15(11):1009-1016.
[12] DAVIES LC, HELDRING N, KADRI N, et al. Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression. Stem Cells. 2017;35(3):766-776.
[13] SHAHIR M, MAHMOUD HASHEMI S, et al. Effect of mesenchymal stem cell-derived exosomes on the induction of mouse tolerogenic dendritic cells. J Cell Physiol. 2020;235(10):7043-7055.
[14] YOO S, HA SJ. Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications. Immune Netw. 2016;16(1):52-60.
[15] PENG Y, CHEN B, ZHAO J, et al. Effect of intravenous transplantation of hUCB-MSCs on M1/M2 subtype conversion in monocyte/macrophages of AMI mice. Biomed Pharmacother. 2019;111:624-630.
[16] TAO Z, TAN S, CHEN W, et al. Stem Cell Homing: a Potential Therapeutic Strategy Unproven for Treatment of Myocardial Injury. J Cardiovasc Transl Res. 2018;11(5):403-411.
[17] LI X, HE XT, YIN Y, et al. Administration of signalling molecules dictates stem cell homing for in situ regeneration. J Cell Mol Med. 2017;21(12): 3162-3177.
[18] TIAN XQ, YANG YJ, LI Q, et al. Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating SDF-1/CXCR4 axis. Am J Transl Res. 2019;11(7):4214-4231.
[19] TAO X, SUN M, CHEN M, et al. HMGB1-modified mesenchymal stem cells attenuate radiation-induced vascular injury possibly via their high motility and facilitation of endothelial differentiation. Stem Cell Res Ther. 2019;10(1):92.
[20] SEGERS VF, VAN RIET I, ANDRIES LJ, et al. Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol. 2006;290(4):H1370-1377.
[21] GAO LR, CHEN Y, ZHANG NK, et al. Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial. BMC Med. 2015;13:162.
[22] KIM SH, CHO JH, LEE YH, et al. Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction. Cardiovasc Drugs Ther. 2018;32(4):329-338.
[23] FLOREA V, RIEGER AC, DIFEDE DL, et al. Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study). Circ Res. 2017;121(11): 1279-1290.
[24] XU J, XIONG YY, LI Q, et al. Optimization of Timing and Times for Administration of Atorvastatin-Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction. Stem Cells Transl Med. 2019;8(10):1068-1083.
[25] ZHANG B, ZHANG J, ZHU D, et al. Mesenchymal stem cells rejuvenate cardiac muscle after ischemic injury. Aging (Albany NY). 2019;11(1): 63-72.
[26] ASSIS AC, CARVALHO JL, JACOBY BA, et al. Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplant. 2010;19(2):219-230.
[27] ZLABINGER K, LUKOVIC D, HEMETSBERGER R, et al. Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery. Front Bioeng Biotechnol. 2018;6:35.
[28] DONG Y, HONG M, DAI R, et al. Engineered bioactive nanoparticles incorporated biofunctionalized ECM/silk proteins based cardiac patches combined with MSCs for the repair of myocardial infarction: In vitro and in vivo evaluations. Sci Total Environ. 2020;707:135976.
[29] PARK SJ, KIM RY, PARK BW, et al. Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction. Nat Commun. 2019;10(1):3123.
[30] LUGER D, LIPINSKI MJ, WESTMAN PC, et al. Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy. Circ Res. 2017;120(10):1598-1613.
[31] GAGGI G, IZZICUPO P, DI CREDICO A, et al. Spare Parts from Discarded Materials: Fetal Annexes in Regenerative Medicine. Int J Mol Sci. 2019; 20(7):1573.
[32] MARDPOUR S, HAMIDIEH AA, TALEAHMAD S, et al. Interaction between mesenchymal stromal cell-derived extracellular vesicles and immune cells by distinct protein content. J Cell Physiol. 2019;234(6):8249-8258.
[33] DU W, LI X, CHI Y, et al. VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity. Stem Cell Res Ther. 2016;7:49.
[34] KIM PJ, MAHMOUDI M, GE X, et al. Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium. Circ Res. 2015;116(7):e40-50.
[35] NI J, LIU X, YIN Y, et al. Exosomes Derived from TIMP2-Modified Human Umbilical Cord Mesenchymal Stem Cells Enhance the Repair Effect in Rat Model with Myocardial Infarction Possibly by the Akt/Sfrp2 Pathway. Oxid Med Cell Longev. 2019;2019:1958941.
[36] LI L, TANG P, ZHOU Z, et al. GIT1 regulates angiogenic factor secretion in bone marrow mesenchymal stem cells via NF-κB/Notch signalling to promote angiogenesis. Cell Prolif. 2019;52(6):e12689.
[37] LIANG X, DING Y, LIN F, et al. Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathways. FASEB J. 2019;33(3):4559-4570.
[38] SHENG L, MAO X, YU Q, et al. Effect of the PI3K/AKT signaling pathway on hypoxia-induced proliferation and differentiation of bone marrow-derived mesenchymal stem cells. Exp Ther Med. 2017;13(1):55-62.
[39] TU J, WAN C, ZHANG F, et al. Genetic correction of Werner syndrome gene reveals impaired pro-angiogenic function and HGF insufficiency in mesenchymal stem cells. Aging Cell. 2020;19(5):e13116.
[40] ZHANG L, JIAO G, REN S, et al. Exosomes from bone marrow mesenchymal stem cells enhance fracture healing through the promotion of osteogenesis and angiogenesis in a rat model of nonunion. Stem Cell Res Ther. 2020;11(1):38.
[41] VENTURA FERREIRA MS, BIENERT M, Müller K, et al. Comprehensive characterization of chorionic villi-derived mesenchymal stromal cells from human placenta. Stem Cell Res Ther. 2018;9(1):28.
[42] PILNY E, SMOLARCZYK R, JAROSZ-BIEJ M, et al. Human ADSC xenograft through IL-6 secretion activates M2 macrophages responsible for the repair of damaged muscle tissue. Stem Cell Res Ther. 2019;10(1):93.
[43] KHODAYARI S, KHODAYARI H, AMIRI AZ, et al. Inflammatory Microenvironment of Acute Myocardial Infarction Prevents Regeneration of Heart with Stem Cells Therapy. Cell Physiol Biochem. 2019;53(5):887-909.
[44] MARTIN-RENDON E, SWEENEY D, LU F, et al. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang. 2008;95(2):137-148.
[45] LEE WC, SEPULVEDA JL, RUBIN JP, et al. Cardiomyogenic differentiation potential of human adipose precursor cells. Int J Cardiol. 2009;133(3): 399-401.
[46] WAN SAFWANI WK, MAKPOL S, SATHAPAN S, et al. 5-Azacytidine is insufficient for cardiogenesis in human adipose-derived stem cells. J Negat Results Biomed. 2012;11:3.
[47] XU H, ZHOU Q, YI Q, et al. Islet-1 synergizes with Gcn5 to promote MSC differentiation into cardiomyocytes. Sci Rep. 2020;10(1):1817.
[48] CAO Y, ZHUANG Y, CHEN J, et al. Dynamic effects of Fto in regulating the proliferation and differentiation of adult neural stem cells of mice. Hum Mol Genet. 2020;29(5):727-735.
[49] WU Y, XIE L, WANG M, et al. Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat Commun. 2018;9(1):4772.
[50] DENG R, LIU Y, HE H, et al. Haemin pre-treatment augments the cardiac protection of mesenchymal stem cells by inhibiting mitochondrial fission and improving survival. J Cell Mol Med. 2020;24(1):431-440.
[51] MAO Q, LIANG XL, WU YF, et al. ILK promotes survival and self-renewal of hypoxic MSCs via the activation of lncTCF7-Wnt pathway induced by IL-6/STAT3 signaling. Gene Ther. 2019;26(5):165-176.
[52] SONG X, SU L, YIN H, et al. Effects of HSYA on the proliferation and apoptosis of MSCs exposed to hypoxic and serum deprivation conditions. Exp Ther Med. 2018;15(6):5251-5260.
[53] KORNICKA K, MARYCZ K, MARĘDZIAK M, et al. The effects of the DNA methyltranfserases inhibitor 5-Azacitidine on ageing, oxidative stress and DNA methylation of adipose derived stem cells. J Cell Mol Med. 2017;21(2):387-401.
|